Download PDF
J Pediatr Infect Dis 2021; 16(01): 012-017
DOI: 10.1055/s-0040-1719163
Original Article

Diagnostic Yield of Multiplex PCR Method in Cerebrospinal Fluid for the Diagnosis of Purulent Meningitis in Children

Jing-Li Zhao
1   Department of Infectious Diseases, National Clinical Research Center for Child Health, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China
2   Department of Nephrology, National Clinical Research Center for Child Health, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China
,
Chun-Zhen Hua 
1   Department of Infectious Diseases, National Clinical Research Center for Child Health, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China
,
Yong-Ping Xie
1   Department of Infectious Diseases, National Clinical Research Center for Child Health, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China
,
Yan-Xiang Pan
3   Department of Clinical Laboratory Center, National Clinical Research Center for Child Health, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China
,
Bo-Fei Hu
1   Department of Infectious Diseases, National Clinical Research Center for Child Health, Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China
,
Wei-Jian Wang
4   Department of Research and Development, Health Gene Technologies Co., Ltd., Ningbo, Zhejiang, P.R. China
,
Xiu He
5   Department of Marketing,r Health Gene Technologies Co., Ltd., Ningbo, Zhejiang, P.R. China
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Objective To evaluate the diagnostic yield of the multiplex polymerase chain reaction (PCR) method in cerebrospinal fluid (CSF) for the diagnosis of purulent meningitis (PM) in children.

Methods PM was diagnosed according to the European Society for Clinical Microbiology and Infectious Diseases guideline (2016). Patients with PM between May 2015 and October 2018 were included. The multiplex PCR method was used to detect eight common identified bacteria in PM. Its sensitivity and specificity were compared with bacteria culture.

Results A total of 106 cases were enrolled. Pathogenic bacteria were identified in 27 (25.5%) cases by culture and in 37 (34.9%) cases by multiplex PCR assay. The top three bacteria were Streptococcus pneumoniae, Escherichia coli K1, and Streptococcus agalactiae. When using culture as the gold standard, the multiplex PCR assay showed a sensitivity of 100, 88.9, and 75.0% for S. agalactiae, S. pneumoniae, and E. coli K1, respectively, and a specificity of more than 91.3% for all three bacteria. For detectable bacteria, the positive rate of the multiplex PCR assay (36.6%, 37/101) was significantly higher than that of the bacteria culture (21.8%, 22/101). When combining the two methods, etiology was identified in 42.5% (45/106) of the patients.

Conclusion Streptococcus pneumoniae, E. coli K1, and S. agalactiae were the predominant pathogens causing pediatric PM. As a rapid method with high sensitivity and specificity, the multiplex PCR assay in CSF could be used as an adjunctive approach with bacteria culture for the pathogen identification of PM.

Keywords

purulent meningitis - multiplex PCR - pathogen - pediatric - cerebrospinal fluid

Authors' Contributions

J.L.Z. took part in data curation, investigation, formal analysis, and writing the original draft. C.Z.H. contributed in conceptualization, supervision, writing—reviewing and editing, final approval of manuscript. Y.P.X. took part in collecting resources, and writing—reviewing and editing. Y.X.P. took part in investigation, along with writing—reviewing and editing. B.F.H contributed in resources, along with writing—reviewing and editing. W.J.W. contributed in investigation, apart from writing—reviewing and editing. X.H. contributed in writing methodology, reviewing and editing of the manuscript. All authors approve the final manuscript and agree to be accountable for all aspects of the work.




Publication History

Received: 24 May 2020

Accepted: 30 September 2020

Article published online:
19 November 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine 2009; 27 (Suppl. 02) B51-B63
    CrossrefPubMedGoogle Scholar
  • 2 Thaver D, Zaidi AK. Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J 2009; 28 (01) S3-S9
    CrossrefPubMedGoogle Scholar
  • 3 Chauhan D, Mokta K, Kanga A, Grover N. Epidemiology, clinical profile and role of rapid tests in the diagnosis of acute bacterial meningitis in children (aged 1-59 months). Neurol India 2018; 66 (04) 1045-1049
    CrossrefPubMedGoogle Scholar
  • 4 Li Y, Yin Z, Shao Z. Acute Meningitis and Encephalitis Syndrome Study Group. et al. Population-based surveillance for bacterial meningitis in China, September 2006-December 2009. Emerg Infect Dis 2014; 20 (01) 61-69
    PubMedGoogle Scholar
  • 5 Agrawal S, Nadel S. Acute bacterial meningitis in infants and children: epidemiology and management. Paediatr Drugs 2011; 13 (06) 385-400
    CrossrefPubMedGoogle Scholar
  • 6 Edmond K, Clark A, Korczak VS, Sanderson C, Griffiths UK, Rudan I. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10 (05) 317-328
    CrossrefPubMedGoogle Scholar
  • 7 van de Beek D. Progress and challenges in bacterial meningitis. Lancet 2012; 380 (9854): 1623-1624
    CrossrefPubMedGoogle Scholar
  • 8 Leber AL, Everhart K, Balada-Llasat JM. et al. Multicenter evaluation of BioFire FilmArray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol 2016; 54 (09) 2251-2261
    CrossrefPubMedGoogle Scholar
  • 9 Graf EH, Farquharson MV, Cárdenas AM. Comparative evaluation of the FilmArray meningitis/encephalitis molecular panel in a pediatric population. Diagn Microbiol Infect Dis 2017; 87 (01) 92-94
    CrossrefPubMedGoogle Scholar
  • 10 van de Beek D, Cabellos C, Dzupova O. ESCMID Study Group for Infections of the Brain (ESGIB). et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect 2016; 22 (Suppl. 03) S37-S62
    CrossrefPubMedGoogle Scholar
  • 11 Long F, Kong M, Wu S. et al. Development and validation of an advanced fragment analysis-based assay for the detection of 22 pathogens in the cerebrospinal fluid of patients with meningitis and encephalitis. J Clin Lab Anal 2019; 33 (03) e22707
    CrossrefPubMedGoogle Scholar
  • 12 Takhar SS, Ting SA, Camargo Jr CA, Pallin DJ. U.S. emergency department visits for meningitis, 1993-2008. Acad Emerg Med 2012; 19 (06) 632-639
    CrossrefPubMedGoogle Scholar
  • 13 George BP, Schneider EB, Venkatesan A. Encephalitis hospitalization rates and inpatient mortality in the United States, 2000-2010. PLoS One 2014; 9 (09) e104169
    CrossrefPubMedGoogle Scholar
  • 14 Nigrovic LE, Fine AM, Monuteaux MC, Shah SS, Neuman MI. Trends in the management of viral meningitis at United States children's hospitals. Pediatrics 2013; 131 (04) 670-676
    CrossrefPubMedGoogle Scholar
  • 15 Afifi S, Wasfy MO, Azab MA. et al. Laboratory-based surveillance of patients with bacterial meningitis in Egypt (1998-2004). Eur J Clin Microbiol Infect Dis 2007; 26 (05) 331-340
    CrossrefPubMedGoogle Scholar
  • 16 Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 2010; 23 (03) 467-492
    CrossrefPubMedGoogle Scholar
  • 17 Wootton SH, Aguilera E, Salazar L, Hemmert AC, Hasbun R. Enhancing pathogen identification in patients with meningitis and a negative Gram stain using the BioFire FilmArray(®) Meningitis/Encephalitis panel. Ann Clin Microbiol Antimicrob 2016; 15: 26
    CrossrefPubMedGoogle Scholar
  • 18 Soucek DK, Dumkow LE, VanLangen KM, Jameson AP. Cost justification of the BioFire FilmArray meningitis/encephalitis panel versus standard of care for diagnosing meningitis in a community hospital. J Pharm Pract 2019; 32 (01) 36-40
    CrossrefPubMedGoogle Scholar
  • 19 Du B, Hua C, Xia Y. et al. Evaluation of the BioFire FilmArray meningitis/encephalitis panel for the detection of bacteria and yeast in Chinese children. Ann Transl Med 2019; 7 (18) 437
    CrossrefPubMedGoogle Scholar
  • 20 Qazi SA, Khan MA, Mughal N. et al. Dexamethasone and bacterial meningitis in Pakistan. Arch Dis Child 1996; 75 (06) 482-488
    CrossrefPubMedGoogle Scholar
  • 21 Seth R, Murthy PSR, Sistla S, Subramanian M, Tamilarasu K. Rapid and accurate diagnosis of acute pyogenic meningitis due to Streptococcus pneumoniae, Haemophilus influenzae type b and Neisseria meningitidis using a multiplex PCR assay. J Clin Diagn Res 2017; 11 (09) FC01-FC04
    PubMedGoogle Scholar
  • 22 Le Saux N. Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Guidelines for the management of suspected and confirmed bacterial meningitis in Canadian children older than one month of age. Paediatr Child Health 2014; 19 (03) 141-152
    CrossrefPubMedGoogle Scholar
  • 23 Lee CK, Chiu L, Yan G. et al. False negative results caused by erroneous automated result interpretation algorithm on the FilmArray 2.0 instrument. Clin Chem Lab Med 2018; 56 (02) e43-e45
    CrossrefPubMedGoogle Scholar